Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00027742 · COMPLETED

Trial details

NCT number: NCT00027742
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 2001-05-01
Primary completion: 2005-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.